IN THE NEWS
PRESS
The New York Times: Heart Problem More Common After Covid-19 Than After Vaccination
The New York Times: The Pfizer vaccine’s initial success holds up in wider use
The New York Times: A Cure for an Assortment of Ills
The New York Times: Charting the Candidates
The Wall Street Journal: Pfizer’s Covid-19 Vaccine Is Equally Effective for Young and Old
ABC News: Doctors May Be Able to Predict Domestic Abuse
ABC News: Travel time to abortion facilities has quadrupled post-Roe
NBC News: Artificial intelligence program diagnoses abuse
NBC News: Pfizer Covid-19 vaccine works well in big 'real world' test
NBC News: When the Red Sox are hot, ERs cool down
NBC News: Travel time for abortions tripled and requests for pills soared
CBS News: 1 in 3 women of reproductive age now live over an hour away from an abortion clinic
CNN: Vaccines work in the real world, new data shows
CNN: Covid vaccine much safer than catching the virus
CNN: A cocoon of vaccination provides ‘substantial’ protection for unvaccinated kids
CNN: The case for Covid boosters just got stronger
CNN: Travel time to abortion facilities grew significantly after Supreme Court overturned Roe v. Wade
Time: COVID-19 Vaccines Work. Here’s the Real-World Proof
BBC: Will complacency damage Covid booster rollout?
The White House: Become a Flu Fighter
The Atlantic: Interesting little tool to use during tonight's speech
The Atlantic: Presidents and the 7 deadly sins
U.S. News & World Report: Predicting Bad Drug Reactions Before They Happen
U.S News & World Report: The History of the Word "Recession" in the State of the Union Address
The Telegraph: Pfizer vaccine's second dose boosts protection dramatically
Forbes: Vaccinated Teens 90% Less Likely To Contract Delta Variant In First Few Weeks After Second Dose
Bloomberg: Pfizer - BioNTech Shot Could Help End Pandemic
Bloomberg: Pfizer Jab Effective Against Delta Variant in Teens
Reuters: Electronic medical records could spot abuse: study
Reuters: In boost for COVID-19 battle, Pfizer vaccine found 94% effective in real world
Reuters: Heart attack patients with COVID-19 have lower survival rate;
Reuters: Pfizer vaccine very effective against Delta variant in adolescents in Israel
Reuters: Heart inflammation risk boosted slightly by vaccine, more by COVID-19
NPR: The Speech in Graphics
The New Republic: The Origins Of Inaugural Speech Kitsch
The New Republic: Will Obama Talk Turkey This Evening?
The New Republic: 2,126 'Buts,' and 55 'Reagans'
LA Times: Pfizer’s vaccine trial data holds up in the real world
Wired: Data-Mining Medical Records Could Predict Domestic Violence
The Huffington Post: Bush, Iraq, Energy, Osama: McCain/Obama Speech War
The Huffington Post: Obama's and McCain's Green Promises Are Just a Matter of Speech
Le Monde: Obama et la note de "43"
Die Welt: Die kuriosen Meldungen zum US-Wahlkampf
CTV: Pfizer COVID-19 booster shot reduces severity of disease
Times of India: Covid booster dose effective in reducing severe disease outcomes
Sydney Morning Herald: Booster shots made available for all NSW adults
New Scientist: Computer Detects Abuse Before Doctors
Discover Magazine: To Detect Domestic Abuse Earlier, Call in a Robo-Doc
Yahoo News: Dr. Fauci Just Urged Vaccinated People Not to Do This
Yahoo News: New large study provides 'clear evidence' for Pfizer vaccine safety
Haaretz: This Harvard Scientist Is Developing a Tool That Predicts Suicide Years Before It Happens
The Jerusalem Post: COVID more likely to cause serious side effects than vaccine
Freakonomics: Quantifying the President's Speech
Freakonomics: The Empiricist in Chief
New Atlas: Model predicts suicide attempts two years ahead using health records
Earth.com: Computer models predict suicide risk through health records
PODCASTS
Trailblazers with Walter Isaacson
TELEVISION
Today Show, Australian National News: Covid-19 Vaccination
Bloomberg TV News, Coronavirus Vaccination
ZDF National TV News, Germany, Coronavirus vaccination
i24 News: Unvaccinated Coronavirus Patients Face More Risks
KTLA 5: Harvard Medical School researcher Dr. Ben Reis breaks down COVID studies on delta variant